Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, November 04, 2022
Medmix Drug Delivery (Haselmeier) and AARDEX Group announced a collaboration, combining Haselmeier´s D-Flex™ Logbook with AARDEX Group’s Medication Adherence software and hardware ecosystem.
read more
Medix Biochemica has acquired 100 percent of the shares of Bioresource Technology ("BRT") to broaden its base matrix capabilities and further strengthen its local presence in the US market.
read more
Wednesday, August 26, 2020
MediWound and Vericel announced the BARDA has accepted the first shipment of NexoBrid
read more
MediWound announced the expansion of its agreement with GENFA MEDICA, granting it the exclusive right to market and distribute NexoBrid® in Ukraine, Lithuania, Latvia, and Estonia.
read more
MediWound announced the expansion of its NexoBrid® European presence with distribution agreements with GENFA MEDICA and Specialty Therapeutics.
read more
Thursday, January 02, 2020
MediWound announced the signing of a distribution agreement granting Balance Medical the exclusive rights to market and distribute NexoBrid® in Australia, New Zealand and Singapore for the treatment of severe burns.
read more
Thursday, November 05, 2015
Medivo, Inc., a lab data analytics company, announced that it has formed a nonexclusive laboratory data licensing agreement with Quest Diagnostics, a provider of diagnostic information services.
read more
Wednesday, September 16, 2015
Medivir AB has announced that, as the next step in the company's optimization process, its research and development operations will be merged into a joint unit as of 1 October 2015, headed by Richard Bethell who will hold the new title of EVP ...
read more
Tuesday, February 16, 2021
Ubiquigent has entered into a license agreement with Medivir for Medivir’s preclinical USP7 research program.
read more
Medivir AB has announced that the acquisitions of the two clinical stage oncology programs from TetraLogic Pharmaceuticals Corporation have been completed.
read more
Wednesday, November 09, 2016
MediSapiens, a Finnish developer and provider of genomic and healthcare data solutions, extends is solution delivery network by offering its Explorer™ Platform based genomic, clinical and biomedical data curation, management and analytics solutions ...
read more
Thursday, September 06, 2018
WuXi AppTec congratulates its partner Hutchison MediPharma on receiving approval of Fruquintinib capsules (Elunate) for metastatic colorectal cancer from the NMPA.
read more
Tuesday, December 17, 2024
MediPharm Labs Corp. and Kensana Health Inc. have entered into a share purchase agreement for the purchase and sale of MediPharm's facility in Napanee, Ontario for $5.5 million in cash.
read more
Wednesday, August 05, 2015
AstraZeneca has announced that MedImmune, its global biologics research and development arm, has entered into an exclusive clinical trial collaboration with Mirati Therapeutics, Inc., an oncology company focusing on genetic and epigenetic drivers of ...
read more
Thursday, September 08, 2022
Medigen is doubling the amount of space leased at Riverside Technology Park in Frederick, Maryland to 12,000 square feet, which represents the second time the biotech company has expanded its operations at 8420 Gas House Pike within the last 36 ...
read more